Delivery Order SPE2DB24D2212-SPE2DB25FHQST
- Not listed
- The Defense Logistics Agency awarded a $4,171.54 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $17,652.82 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 20, 2025, with performance at the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $29,266.54 delivery order on August 18, 2025, for Dupixent (dupilumab) 300 mg/2 mL syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $47,457.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitive award, with no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-transaction procurement under AmerisourceBergen's broader Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Dupixent 300mg/2ml syringes valued at $44,390.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $9,986.44 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. This competitively awarded, firm fixed-price contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $1,709.46 to supply Dupixent 200 mg/1.14 ml syringes. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,709.46 for Dupixent 300 mg/2 mL syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a $5,140.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on May 16, 2025, with an ultimate completion date of May 19, 2025. This non-set-aside competitive award is being performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $1,709.46. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQSTDelivery Order
The Defense Logistics Agency awarded a $18,494.66 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed-price, non-competitive set-aside contract with a completion date of September 5, 2025, with the place of performance located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serving as a critical vendor for federal medical procurement across the Department of Defense and broader federal healthcare systems. The company holds a robust portfolio of competitively awarded contracts with the Defense Logistics Agency covering a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities in multiple therapeutic domains. This delivery order for Dupixent, a specialty pharmaceutical used in the treatment of eczema and other inflammatory conditions, reflects the company's ongoing role as a prime vendor supporting military healthcare operations globally through the DLA Troop Support Medical prime indefinite delivery contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 9/4/25 |